Navigation Links
KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard
Date:4/18/2012

ttei, national tax leader of KPMG's Pharmaceutical and Medical Device practice.  "Companies will need to become familiar with the excise tax rules, identify their affected entities and products, and develop the appropriate compliance processes.  A 'gap' analysis should be conducted as soon as possible to identify areas that need to be addressed."

The KPMG survey also reveals that, in response to the tax, many medical device industry companies are already considering actions that they believe will help them stay competitive.  Twenty-two percent of respondents said their companies would most likely consider increasing the cost of goods sold to the purchaser, while 13 percent said their organizations would most likely consider making cost reductions in areas such as headcount and manufacturing processes.  Fifty percent said they were unsure about the actions their company might take.

Thirty-five percent of respondents to the KPMG survey said their company is currently working across several departments to prepare for the implementation of the excise tax regime.  Nine percent said steps were being taken to prepare for the implementation within the tax department only, while 30 percent said they were not taking any steps to prepare because they were either still trying to understand the implications or evaluate their options.

"Companies need to work across various functions to prepare for effective compliance, because this is not just a tax issue," said Adam Uttley, a KPMG tax partner focused on accounting methods, credits, and special projects.  "Finance and tax departments will need to work with their IT, operations, and regulatory counterparts, while keeping leadership informed of issues that could affect the business.

"Although many may still be hoping for legislative relief, it would be prudent to assume that a first deposit of medical device excise tax will be due by January 29, 2013, and the first quarterly
'/>"/>

SOURCE KPMG LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alzheimers Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors
2. National Foundation for Infectious Diseases (NFID) Survey: Parents More Flu Aware and More Likely to Get Kids Vaccinated
3. New Survey: Walgreens Customers Flock to Independent Pharmacies
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Globus Medical Raises $110 Million in Series E Financing Round
8. Quark Pharmaceuticals Appoints New Chief Medical Officer
9. Boston University Biomedical Engineers Find Chink in Bacterias Armor
10. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
11. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... SALT LAKE CITY , Sept. 15, 2014 ... innovative minimally invasive surgical (MIS) visualization products, is ... 13485:2003 certification for its quality management system (QMS) ... is another important step in Olive Medical complying ... of medical devices.  It is the goal of ...
(Date:9/15/2014)... CHICAGO , Sept. 15, 2014  The Female ... Tayler will join the Company,s management team as ... 2014.  The Company also announced that Michael Pope ... U.K. and Malaysian Operations, effective September 15, 2014.  Following ... the Company as a Consultant. Prior to ...
(Date:9/15/2014)... , Sept. 15, 2014   Royal Philips ... its growing range of advanced women,s healthcare imaging solutions ... Society for Ultrasound in Obstetrics and Gynecology (ISUOG) World ... Spain . "We,re continually investing ... efficiency and outcomes," said Vitor Rocha , CEO ...
Breaking Medicine Technology:Olive Medical Achieves ISO 13485:2003 Certification 2The Female Health Company Appoints Martin Tayler Executive Vice President of Global Operations 2The Female Health Company Appoints Martin Tayler Executive Vice President of Global Operations 3Philips Showcases Ultrasound Innovations that Address Clinical Challenges in the OB/GYN Segment at ISUOG World Congress 2Philips Showcases Ultrasound Innovations that Address Clinical Challenges in the OB/GYN Segment at ISUOG World Congress 3
... , June 21 ViroPharma Incorporated (Nasdaq: ... Cinryze™ (C1 Esterase Inhibitor [Human]) manufacturing expansion activities.   , ... ViroPharma ...  The first project, the parallel chromatography process, was implemented earlier ...
... , MISGAV, Israel , ... of laparoscopic soft tissue prosthetic placement,technologies, today announced that it ... an innovative laparoscopic,surgical instrument that enables accurate and rapid delivery ... including laparoscopic,ventral hernia repair (LVHR). , ...
Cached Medicine Technology:ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 2ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 3ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 4ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 5ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 6PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects 2PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects 3
(Date:9/15/2014)... Global Health Innovative Technology Fund (GHIT Fund), a ... know-how and investment to the global fight against ... US$15.3 million to speed the development of promising ... dengue and Chagas disease. The announcement marks the ... November 2013totaling $33.5 millionaimed at diseases that sicken ...
(Date:9/15/2014)... September 15, 2014 Ondine Biomedical ... Loebel, its President and Chief Technology Officer, will ... Photodynamic Therapy (PDT) and Photodiagnosis in Clinical Practice. ... Brixen/Bressanone (Italy) from October 14-18, 2014 alongside the ... on October 13-14th, is an annual conference at ...
(Date:9/15/2014)... VA (PRWEB) September 15, 2014 ... and management consulting services to the federal government, ... in Alexandria, Virginia and Atlanta, Georgia to better ... catalyst for this expansion is credited to the ... in the core areas of management consulting, agile ...
(Date:9/15/2014)... out of every 40 individuals in the United States is ... (SMA), a neurodegenerative disease that causes muscles to weaken over ... a recent breakthrough with the development of a new compound ... disease. In April, a patent was filed for the compound ... using to fight SMA is to ,repress the repressor," said ...
(Date:9/15/2014)... In order to provide predictability and safety, the ... quantify, define and model medical practice. Defined as Bioinformatics ... medical care. , The Journal of BioAcoustic Biology ( ... non-profit Institute of BioAcoustic Biology, located in Albany, Ohio, ... much more than a measurement tool; math, as frequency, ...
Breaking Medicine News(10 mins):Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 2Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 3Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 4Health News:Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases 5Health News:Ondine Presenting at the 2014 International Symposium on Photodynamic Therapy and Photodiagnosis 2Health News:Octo Consulting Group Announces it is Opening Two New Offices in Alexandria, Virginia and Atlanta, Georgia to Better Serve Existing and Future Federal Government Clients 2Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3
... survival rate of non-small-cell lung cancer patients after ... Cisplatin is an anti-neoplastic medication that interferes with ... growth and spread in the body. ... three or four cycles of cisplatin-based chemotherapy or ...
... the world's first epilepsy drug, an Australian neurologist says.// ... a mild sedative, taken either as a herbal infusion ... form. ,But the Italian author Fabio Colonna first ... botanical work Phytobasanos. ,Colonna said he had controlled ...
... around 700,000 people researchers say dads who have children ... // for developing schizophrenia later in life. ... to the hospital in Sweden between 1989 and 2001 ... Researchers say they found a strong association between the ...
... recent study shows that people who use stomach-acid suppressive ... may be at an increased risk of developing pneumonia ... the stomach can increase vulnerability to infections, as stomach ... Researchers studied pneumonia rates of more than 364,000 patients ...
... study researchers say they have found that the drug ... cancer // decreased patients' cancer incidence after 12 months ... some impact, but the 20-milligram dose had the greatest ... prostatic intraepithelial neoplasia, characterized by abnormal cells in the ...
... New research shows that sleep disorders may be linked ... ADD ), // neuromuscular conditions, and psychiatric problems. ... patients with sleep apnea also had ADD. Results also ... insomnia. Further testing showed some of these patients also ...
Cached Medicine News:Health News:Valerian was first epilepsy drug 2
...
...
... exercise BP monitor is designed to automatically ... diastolic BP along with heart rate. It's ... use in treadmill, ergometer and pharmacological stress ... use in research environments., ,Tango excels ...
...
Medicine Products: